Delicia E. Carey, Ph.D.

Affiliations: 
2000 University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Biostatistics Biology, Public Health, Statistics
Google:
"Delicia Carey"
Cross-listing: PHTree

Parents

Sign in to add mentor
Alfred A. Bartolucci grad student 2000 UAB
 (A Bayesian approach for assessment of therapeutic equivalence of three proportions.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mahasreshti PJ, Kataram M, Wu H, et al. (2006) Ovarian cancer targeted adenoviral-mediated mda-7/IL-24 gene therapy. Gynecologic Oncology. 100: 521-32
Forero A, Meredith RF, Khazaeli MB, et al. (2005) Phase I study of90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: Effect of chelating agents and paclitaxel co-administration Cancer Biotherapy and Radiopharmaceuticals. 20: 467-478
Divers SG, Spencer SA, Carey D, et al. (2005) Phase I/IIa study of cisplatin and gemcitabine as induction chemotherapy followed by concurrent chemoradiotherapy with gemcitabine and paclitaxel for locally advanced non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 6664-73
Spencer S, McCarty HJ, Harper K, et al. (2005) Late Pulmonary Toxicity Associated with Chemotherapy and Radiation for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) International Journal of Radiation Oncology Biology Physics. 63
Leath CA, Kataram M, Bhagavatula P, et al. (2004) Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinoma. Gynecologic Oncology. 94: 352-62
Meredith R, Shen S, Macey D, et al. (2004) Comparison of biodistribution, dosimetry, and outcome from clinical trials of radionuclide-CC49 antibody therapy. Cancer Biotherapy & Radiopharmaceuticals. 18: 393-404
Huh WK, Powell M, Leath CA, et al. (2003) Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy. Gynecologic Oncology. 91: 470-5
Robert F, Busby E, Marques MB, et al. (2003) Phase II study of docetaxel plus enoxaparin in chemotherapy-naive patients with metastatic non-small cell lung cancer: preliminary results. Lung Cancer (Amsterdam, Netherlands). 42: 237-45
Vaughan WP, Carey D, Perry S, et al. (2002) A limited sampling strategy for pharmacokinetic directed therapy with intravenous busulfan. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 8: 619-24
Robert F, Spencer SA, Childs HA, et al. (2002) Concurrent chemoradiation therapy with cisplatin and paclitaxel for locally advanced non-small cell lung cancer: long-term follow-up of a phase I trial. Lung Cancer (Amsterdam, Netherlands). 37: 189-99
See more...